BNP Paribas Financial Markets
PHAR

BNP Paribas Financial Markets’s Pharming Group PHAR Stock Holding History

BNP Paribas Financial Markets’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.66K Sell
400
-400
-50% -$6.78K ﹤0.01% 5283
2025
Q4 		$14.1K Buy
800
+700
+700% +$11K ﹤0.01% 5096
2025
Q3 		$1.45K Buy
+100
New +$1.25K ﹤0.01% 5197

Other funds holding PHAR

SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $240M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SHIM
Stone House Investment Management Tunkhannock, Pennsylvania $558M AUM 14.72% 1-Year Est. Return

BNP Paribas Financial Markets's PHAR Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Pharming Group (PHAR) stake by 50% in Q1 2026, selling an estimated $6.78K and leaving 400 shares worth $6.66K. The position accounts for ﹤0.01% of the portfolio, ranked #5283.

BNP Paribas Financial Markets first reported a position in PHAR in Q3 2025 and has held it in 3 quarters since. The position peaked at $14.1K in Q4 2025. 12 funds tracked by Wall St. Rank hold PHAR as of Q1 2026.

  • BNP Paribas Financial Markets held 400 shares of Pharming Group worth $6.66K as of Q1 2026.
  • BNP Paribas Financial Markets sold 400 Pharming Group shares in Q1 2026, an estimated $6.78K.
  • Pharming Group made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5283 holding.
  • BNP Paribas Financial Markets first reported a position in Pharming Group in Q3 2025 and has held it in 3 quarters since.
  • BNP Paribas Financial Markets's Pharming Group position peaked at $14.1K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Pharming Group as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.